From Medscape Oncology

Coverage from the

World Conference on Gastrointestinal Cancer (WCGC) 2019

July 03 - 06, 2019; Barcelona, Spain

July 03 - 06, 2019 Barcelona, Spain

Conference News

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from WCGC 2018

  • Gut Microbiome 'May Hold Key to Immunotherapy Outcomes' Gut Microbiome 'May Hold Key to Immunotherapy Outcomes' The microbial make-up of the gut, or microbiome, appears to play a key role in the risk for colorectal cancer, as well as whether immunotherapies will be successful.
  • Explosion in GI Cancer Drugs 'Confusing for Clinicians' Explosion in GI Cancer Drugs 'Confusing for Clinicians' Clinicians have a confusing picture of which drugs to choose for gastrointestinal cancers, owing to the way trials are designed, although help is at hand from clinical assessment tools, argue experts.
  • Ramucirumab Improves Survival in Poor-Prognosis HCC Ramucirumab Improves Survival in Poor-Prognosis HCC Patients with hepatocellular carcinoma who have high levels of a protein linked to a poor prognosis derive a significant survival benefit with ramucirumab, the results of a pooled analysis reveal.

Previous Coverage